Skip to content

Price / sales at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
14.5×+3.3×
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
132.1×+102×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
24.8×-26.8×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
11.7×+5.0×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
5.1×-0.4×
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
210.5×-3,896×

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.24B+128%
Enterprise value$4.06B+139%
P/E58×

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0.0×
Current ratio3.8×+0.1×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

Based on the most recent quarter.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's price / sales?
Kiniksa Pharmaceuticals International, plc (KNSA) reported price / sales of 4.9× in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's price / sales changed year-over-year?
Kiniksa Pharmaceuticals International, plc's price / sales increased by 45.7% year-over-year, from 3.4× to 4.9×.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's price / sales?
Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's price / sales has grown at a -31.6% compound annual growth rate (CAGR), from 21× to 4.6×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.